Elekta AB (publ) (OTCMKTS:EKTAY) Hits New 12-Month Low – Should You Sell?

Elekta AB (publ) (OTCMKTS:EKTAY) reached a new 52-week low on Wednesday . The stock traded as low as $5.57 and last traded at $5.58, with a volume of 19699 shares traded. The stock had previously closed at $5.72.

Elekta AB (publ) Trading Up 2.0 %

The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.74 and a current ratio of 0.99. The stock has a market capitalization of $2.17 billion, a P/E ratio of 20.18 and a beta of 1.23. The stock has a 50-day moving average price of $6.38 and a two-hundred day moving average price of $6.57.

Elekta AB (publ) (OTCMKTS:EKTAY) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.04 earnings per share for the quarter. The business had revenue of $359.76 million for the quarter. Elekta AB (publ) had a net margin of 6.25% and a return on equity of 12.23%. On average, research analysts forecast that Elekta AB will post 0.41 EPS for the current fiscal year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.